Rebecca Levin
Affiliations: | 2012-2016 | Cellular and Molecular Pharmacology | University of California, San Francisco, San Francisco, CA |
Google:
"Rebecca Levin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Turnham RE, Pitea A, Jang GM, et al. (2024) HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma. Cancer Research |
| Coles GL, Cristea S, Webber JT, et al. (2020) Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Cancer Cell |
| Loonat AA, Martin ED, Sarafraz-Shekary N, et al. (2019) p38γ MAPK contributes to left ventricular remodeling after pathologic stress and disinhibits calpain through phosphorylation of calpastatin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701545R |
| Hernández-Ortega S, Sánchez-Botet A, Quandt E, et al. (2019) Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex. Experimental & Molecular Medicine. 51: 44 |
| Donnella HJ, Webber JT, Levin RS, et al. (2018) Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nature Chemical Biology |
| Lazarus MB, Levin RS, Shokat KM. (2017) Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response. Cellular Signalling. 29: 78-83 |
| Urisman A, Levin RS, Gordan JD, et al. (2016) An optimized chromatographic strategy for multiplexing in parallel reaction monitoring mass spectrometry: Insights from quantitation of activated kinases. Molecular & Cellular Proteomics : McP |
| Levin RS, Hertz NT, Burlingame AL, et al. (2016) Innate immunity kinase TAK1 phosphorylates Rab1 on a hotspot for posttranslational modifications by host and pathogen. Proceedings of the National Academy of Sciences of the United States of America. 113: E4776-83 |
| Miller RE, Brough R, Bajrami I, et al. (2016) Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib. Molecular Cancer Therapeutics. 15: 1472-84 |
| Saha SK, Gordan JD, Kleinstiver BP, et al. (2016) Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma. Cancer Discovery. 6: 727-39 |